Identification of Genetic, Biochemical and Hormonal Factors Contributing to Atrial Fibrillation

NeuroTherapia, Inc.

Status: Active, not recruiting

Conditions: Atrial Fibrillation

Study type: Observational

Funder types: Other

Identifiers

NCT00599118

8271

Details and patient eligibility

About

The purpose of this study is to establish a genebank repository of blood samples and data to generate information about the hereditary (genetic) basis of atrial fibrillation.

Full description

Blood samples and data will be collected from subjects with atrial fibrillation and normal controls. The primary aim of future research using these samples is to identify mechanisms and pathogenesis of atrial fibrillation. Through this information, we hope to identify targets for new therapies and improve knowledge and understanding of atrial fibrillation. Identification of disease genes could improve strategies that prevent progression of atrial fibrillation to more persistent disease.

Enrollment: 1,300 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria for Atrial Fibrillation group:

• Male or female at least 18 years old
• Subjects with a history of or current Atrial Fibrillation
• Subjects able to give informed consent Exclusion Criteria for Atrial Fibrillation group: no history of atrial fibrillation

Inclusion Criteria for Controls:

• Male or female at least 18 years old
• Subjects with no history of Atrial Fibrillation
• Subjects able to give informed consent Exclusion Criteria for controls: History of atrial fibrillation

Trial design

1,300 participants in 2 patient groups

atrial fibrillation

Description:

Atrial fibrillation

Control

Description:

Control subjects with no atrial fibrillation